Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, October 22, 2026

Back to today

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical or safety concerns.

UNCY $110M
Triple S Special Situations Investing 4 clicks

From X

@calvinblissett

Calvin Blissett on X

$CCLD crazy important earnings. Questions and things to monitor: new AI products, cybersecurity any and all information (loss of sales momentum, loss of current clients, still covered by insurance, lawsuits), why no acquisitions, are they still focused on acquisitions or spending more time developing AI products, is the person leading the AI strategy fit to lead it? At what point are buybacks considered despite the phenomenal ROI from acquisition.
@StableBread 2 clicks

Fajasy on X

I tried to work out who’s behind the AI data labeling companies that approached Nubeva Technologies $NBVAF (TSXV: $NBVA). CEO Randy Chou didn’t name the data labeling companies (firms that turn experts’ knowledge into training data for AI labs) or the customers behind them. “If a data labeling company’s coming to us, somebody behind them is asking,” Chou said, adding that the customer typically isn’t limited to cybersecurity companies. OpenAI is one potential candidate, since my previous write-up concluded that the frontier model Nubeva got access to in September was most likely OpenAI’s, through its Daybreak program for vetted defenders. OpenAI launched GPT-6 Astra on September 3, 2026, the day Nubeva announced its access. It’s the first model OpenAI rated Critical for cybersecurity capability. But access to OpenAI’s model wouldn’t prove OpenAI is also behind the data labeling companies, since any lab building cyber models could want labeled malware. Among data labeling companies, three of the largest are publicly recruiting or selling binary analysis expertise, the skill of figuring out what malware programs do: → Scale AI: Its product manager posting calls the cybersecurity portfolio “a product line that does not exist yet” and says the hire will recruit “malware analysts.” → Turing: Sells CyberBench, security tasks for training and testing frontier models, with malware analysis and reverse engineering among its ten categories. TechCrunch called Turing “a key coding provider for OpenAI” in March 2025. → Mercor: Recruits security experts, preferring reverse engineering or binary analysis backgrounds, and counts OpenAI, Anthropic, and Meta $META as customers. OpenAI cut ties with Scale in June 2025, after Meta bought 49% of Scale and hired its founder, Alexandr Wang. So if OpenAI is behind the approach, Turing and Mercor are the likeliest data labeling companies, since both sell to OpenAI and already sell or buy binary analysis expertise. Either way, these data labeling companies are worth $2.2-29B, so even Turing, the smallest, could pay the top of my $12-19M sale range for Nubeva for less than 1% of its last valuation.
@KEDM_COM

KEDM.com on X

A small but interesting one. Bombe AM disclosed a small stake in Mobile Infrastructure $BEEP and is thinking about taking BEEP private. The Chairman and CEO, Manuel Chavez, and the CEO, Stephanie Hogue, are Bombe partners. No price has been offered yet, as Bombe wants due diligence on property performance, capital needs, and capital structure before setting a premium (not our words). BEEP owns and operates parking lots. Shares have been under pressure as earnings don't cover interest expenses. The thing is now trading at roughly 0.5x book, and it looks like their parking lots are being aggressively amortized on the books.
@stockgutter 1 click

SG on X

I am a skeptic of the current quantum companies but cannot ignore that $IONQ just doubled its cash hoard from $2B to $4B, selling shares/prefunded warrants at $40 (above market) covered 2:1 by warrants with a strike at $69.46. Not a bad move imo. While I agree with critics that the warrants are a bit oppressive, shitcos will have to pay up one way or another to raise $$ in size. There are worse structures. No position in IonQ rn, but considering selling long-dated calls in the 2x inverse ETF $IONZ - I think the underlying will participate strongly in any junk bounce towards year end.

Investor Letters

All letters

Moon River Moly: Research Note

Moon River Moly’s updated Davidson PEA lifts after-tax NPV to $1.24 billion as flotation raises tungsten output 350% and cuts molybdenum…

MRIVF $16M
Atrium Research - Equity Research 3 clicks

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $74M
Calvin Blissett 10 clicks

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

LPTH $492M
Trade Ideas Flow 21 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $303M
TSOH Investment Research 18 clicks
UNCY · long

Unicycive Therapeutics INC

Unicycive Therapeutics fell nearly 50% after a second FDA Complete Response Letter tied to a third-party manufacturer for its primary…

UNCY $110M
Value Investors Club

Twenty Years in the Dark

Tower Properties, $TPRP, went dark after a 2006 squeeze-out cut holders below 300, leaving a Kemper-controlled apartment and office…

TPRP $128M
Orphan REITs 5 clicks

TSOH Weekly Roundup (10/16/2026)

Bumble agreed to a $1.3 billion take-private deal, while Netflix cut about 1,000 jobs and Meta discussed its Muse superintelligence models.

BMBL $783M
TSOH Investment Research 12 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 54 of 247

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.